Paper35563200
Molecular Pharmacology of Inflammation Resolution in Atherosclerosis.
Kotlyarov S and 1 other. Int J Mol Sci, 2022. Cited by 24 papers, by iCite.
Cite this record
ConductScience Library. Molecular Pharmacology of Inflammation Resolution in Atherosclerosis. Papers, record 35563200. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35563200
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Atherosclerosis | Major topic |
| Lipoxins | Major topic |
| Docosahexaenoic Acids | |
| Eicosanoids | |
| Fatty Acids, Unsaturated | |
| Humans | |
| Inflammation | |
| Inflammation Mediators |
Source PubMed
References310
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24899309 | Pro-resolving lipid mediators are leads for resolution physiology. | Nature | 2014 | https://conductscience.org/library/papers/24899309 | PubMed |
| 2 | 18476983 | Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients. | Diabetes Obes Metab | 2008 | https://conductscience.org/library/papers/18476983 | PubMed |
| 3 | 25857211 | The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution. | Semin Immunol | 2015 | https://conductscience.org/library/papers/25857211 | PubMed |
| 4 | 23999103 | Chemerin15 inhibits neutrophil-mediated vascular inflammation and myocardial ischemia-reperfusion injury through ChemR23. | EMBO Rep | 2013 | https://conductscience.org/library/papers/23999103 | PubMed |
| 5 | 24254970 | Protectin DX, a double lipoxygenase product of DHA, inhibits both ROS production in human neutrophils and cyclooxygenase activities. | Lipids | 2014 | https://conductscience.org/library/papers/24254970 | PubMed |
| 6 | 11141472 | Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses. | Am J Pathol | 2001 | https://conductscience.org/library/papers/11141472 | PubMed |
| 7 | 34699386 | The resolvin D1 receptor GPR32 transduces inflammation resolution and atheroprotection. | J Clin Invest | 2021 | https://conductscience.org/library/papers/34699386 | PubMed |
| 8 | 27730665 | Biomarker-guided clinical development of the first-in-class anti-inflammatory FPR2/ALX agonist ACT-389949. | Br J Clin Pharmacol | 2017 | https://conductscience.org/library/papers/27730665 | PubMed |
| 9 | 32052833 | Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. | Eur Heart J | 2020 | https://conductscience.org/library/papers/32052833 | PubMed |
| 10 | 8873680 | Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995. | Circulation | 1996 | https://conductscience.org/library/papers/8873680 | PubMed |
| 11 | 26688348 | Specialized pro-resolving mediators: endogenous regulators of infection and inflammation. | Nat Rev Immunol | 2016 | https://conductscience.org/library/papers/26688348 | PubMed |
| 12 | 20709806 | Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis. | Am J Pathol | 2010 | https://conductscience.org/library/papers/20709806 | PubMed |
| 13 | 34582846 | Resolvin D1, therapeutic target in acute respiratory distress syndrome. | Eur J Pharmacol | 2021 | https://conductscience.org/library/papers/34582846 | PubMed |
| 14 | 22927428 | Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation. | Proc Natl Acad Sci U S A | 2012 | https://conductscience.org/library/papers/22927428 | PubMed |
| 15 | 19321784 | Synthesis of lipoxin A4 by 5-lipoxygenase mediates PPARgamma-dependent, neuroprotective effects of rosiglitazone in experimental stroke. | J Neurosci | 2009 | https://conductscience.org/library/papers/19321784 | PubMed |
| 16 | 31924781 | Neutrophil microvesicles drive atherosclerosis by delivering miR-155 to atheroprone endothelium. | Nat Commun | 2020 | https://conductscience.org/library/papers/31924781 | PubMed |
| 17 | 32757380 | MCTR1 enhances the resolution of lipopolysaccharide-induced lung injury through STAT6-mediated resident M2 alveolar macrophage polarization in mice. | J Cell Mol Med | 2020 | https://conductscience.org/library/papers/32757380 | PubMed |
| 18 | 25866809 | Physiological impact of abnormal lipoxin A₄ production on cystic fibrosis airway epithelium and therapeutic potential. | Biomed Res Int | 2015 | https://conductscience.org/library/papers/25866809 | PubMed |
| 19 | 23953428 | Recent advances in the search for novel 5-lipoxygenase inhibitors. | Basic Clin Pharmacol Toxicol | 2014 | https://conductscience.org/library/papers/23953428 | PubMed |
| 20 | 26296857 | Short-Term, High-Dose Fish Oil Supplementation Increases the Production of Omega-3 Fatty Acid-Derived Mediators in Patients With Peripheral Artery Disease (the OMEGA-PAD I Trial). | J Am Heart Assoc | 2015 | https://conductscience.org/library/papers/26296857 | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42852241 | The neuroimmune axis in cardiovascular disease: from immune activation to inflammatory resolution. | Front Immunol | 2026 | https://conductscience.org/library/papers/42852241 | PubMed |
| 42577494 | The Role of Immunoresolvents in Atherosclerosis: A Mini-Review on Their Biology and Therapeutic Opportunities. | Health Sci Rep | 2026 | https://conductscience.org/library/papers/42577494 | PubMed |
| 42511907 | Reprogramming Inflammatory Macrophages with Specialized Pro-Resolving Lipid Mediators: A Novel Immunotherapeutic Strategy for Asthma. | Biomedicines | 2026 | https://conductscience.org/library/papers/42511907 | PubMed |
| 42287589 | Unveiling anti-atherosclerotic targets of Perilla frutescens through a multi-scale computational framework integrating network pharmacology, single-cell analysis, machine learning, and molecular dynamics. | Bioresour Bioprocess | 2026 | https://conductscience.org/library/papers/42287589 | PubMed |
| 40699690 | The Inflammatory Link of Rheumatoid Arthritis and Thrombosis: Pathogenic Molecular Circuits and Treatment Approaches. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/40699690 | PubMed |
| 40329727 | The Emerging Roles of Resolvins: Potential Diagnostic Biomarkers for Cardiovascular Diseases. | Curr Cardiol Rev | 2026 | https://conductscience.org/library/papers/40329727 | PubMed |
| 39684494 | The Involvement of Resolvins in Pathological Mechanisms of Periodontal Disease Associated with Type 2 Diabetes: A Narrative Review. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39684494 | PubMed |
| 39684449 | Functions of TAM Receptors and Ligands Protein S and Gas6 in Atherosclerosis and Cardiovascular Disease. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39684449 | PubMed |
| 38525390 | Investigating the Effect of Aspirin on apoAI-Induced ATP Binding Cassette Transporter 1 Protein Expression and Cholesterol Efflux in Human Astrocytes. | Adv Biomed Res | 2024 | https://conductscience.org/library/papers/38525390 | PubMed |
| 38504569 | Involvement of Lipids and Lipid Mediators in Inflammation and Atherogenesis. | Curr Med Chem | 2025 | https://conductscience.org/library/papers/38504569 | PubMed |
| 37435114 | Distinct Features of Vascular Diseases in COVID-19. | J Inflamm Res | 2023 | https://conductscience.org/library/papers/37435114 | PubMed |
| 37434032 | Anti-oxidant and Anti-inflammatory Effects of Ethanol Extract from Polygala sibirica L. var megalopha Fr. on Lipopolysaccharide-Stimulated RAW264.7 Cells. | Chin J Integr Med | 2023 | https://conductscience.org/library/papers/37434032 | PubMed |
| 37175869 | Portrayal of NLRP3 Inflammasome in Atherosclerosis: Current Knowledge and Therapeutic Targets. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37175869 | PubMed |
| 37175617 | Atherosclerosis and Inflammation: Insights from the Theory of General Pathological Processes. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37175617 | PubMed |
| 36865918 | Posing the rationale for synthetic lipoxin mimetics as an adjuvant treatment to gold standard atherosclerosis therapies. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/36865918 | PubMed |
| 36840021 | Modulating Inflammation-Mediated Diseases via Natural Phenolic Compounds Loaded in Nanocarrier Systems. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/36840021 | PubMed |
| 36359349 | Critical Role of Inflammation and Specialized Pro-Resolving Mediators in the Pathogenesis of Atherosclerosis. | Biomedicines | 2022 | https://conductscience.org/library/papers/36359349 | PubMed |
| 36297265 | Inhibition Effects of Nippostrongylus brasiliensis and Its Derivatives against Atherosclerosis in ApoE-/- Mice through Anti-Inflammatory Response. | Pathogens | 2022 | https://conductscience.org/library/papers/36297265 | PubMed |
| 36077168 | Immune Function of Endothelial Cells: Evolutionary Aspects, Molecular Biology and Role in Atherogenesis. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36077168 | PubMed |
| 36011386 | Genetic and Epigenetic Regulation of Lipoxygenase Pathways and Reverse Cholesterol Transport in Atherogenesis. | Genes (Basel) | 2022 | https://conductscience.org/library/papers/36011386 | PubMed |
Genes54
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35563200
GET https://conductscience.org/api/papers/v1/35563200/references?page=2